WO1998004694A3 - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding them Download PDFInfo
- Publication number
- WO1998004694A3 WO1998004694A3 PCT/US1997/012884 US9712884W WO9804694A3 WO 1998004694 A3 WO1998004694 A3 WO 1998004694A3 US 9712884 W US9712884 W US 9712884W WO 9804694 A3 WO9804694 A3 WO 9804694A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- proteins
- secreted
- polynucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10508940A JP2001501456A (en) | 1996-07-26 | 1997-07-23 | Secreted proteins and polynucleotides encoding them |
CA002261581A CA2261581A1 (en) | 1996-07-26 | 1997-07-23 | Secreted proteins and polynucleotides encoding them |
EP97936173A EP0937143A2 (en) | 1996-07-26 | 1997-07-23 | Secreted proteins and polynucleotides encoding them |
AU38908/97A AU3890897A (en) | 1996-07-26 | 1997-07-23 | Secreted proteins and polynucleotides encoding them |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/686,878 US5708157A (en) | 1996-07-26 | 1996-07-26 | Secreted proteins and polynucleotides encoding them |
US70208196A | 1996-08-23 | 1996-08-23 | |
US08/686,878 | 1996-08-23 | ||
US08/702,081 | 1996-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998004694A2 WO1998004694A2 (en) | 1998-02-05 |
WO1998004694A3 true WO1998004694A3 (en) | 1998-04-30 |
Family
ID=27103884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/012884 WO1998004694A2 (en) | 1996-07-26 | 1997-07-23 | Secreted proteins and polynucleotides encoding them |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0937143A2 (en) |
JP (1) | JP2001501456A (en) |
AU (1) | AU3890897A (en) |
CA (1) | CA2261581A1 (en) |
WO (1) | WO1998004694A2 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
-
1997
- 1997-07-23 JP JP10508940A patent/JP2001501456A/en active Pending
- 1997-07-23 AU AU38908/97A patent/AU3890897A/en not_active Abandoned
- 1997-07-23 CA CA002261581A patent/CA2261581A1/en not_active Abandoned
- 1997-07-23 WO PCT/US1997/012884 patent/WO1998004694A2/en not_active Application Discontinuation
- 1997-07-23 EP EP97936173A patent/EP0937143A2/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
Non-Patent Citations (5)
Title |
---|
ADAMS M D ET AL: "3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN", NATURE GENETICS, vol. 4, no. 3, pages 256 - 267, XP000611495 * |
JACOBS K ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins.", KEYSTONE SYMPOSIUM ON DENDRITIC CELLS: ANTIGEN PRESENTING CELLS OF T AND B LYMPHOCYTES, TAOS, NEW MEXICO, USA, MARCH 10-16, 1995. JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 0 (21A). 1995. 19. ISSN: 0733-1959, XP002040894 * |
R.J. KAUFMAN ET AL.: "Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 1233 - 1242, XP002041592 * |
R.J. KAUFMAN ET AL.: "Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus", NUCLEIC ACIDS RESEARCH, vol. 19, no. 16, 1991, IRL PRESS LIMITED,OXFORD,ENGLAND, pages 4485 - 4490, XP002041594 * |
R.J. KAUFMAN ET AL.: "The phosphorylation state of eucaryotic initiation factor 2 alters translation efficiency of specific mRNAs", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 946 - 958, XP002041593 * |
Also Published As
Publication number | Publication date |
---|---|
AU3890897A (en) | 1998-02-20 |
WO1998004694A2 (en) | 1998-02-05 |
EP0937143A2 (en) | 1999-08-25 |
CA2261581A1 (en) | 1998-02-05 |
JP2001501456A (en) | 2001-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998007859A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998017687A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1997007198A3 (en) | Dna sequences and secreted proteins encoded thereby | |
WO1999057132A8 (en) | Secreted proteins and polynucleotides encoding them | |
AU3381797A (en) | Secreted proteins and polynucleotides encoding them | |
WO1998033916A8 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998004693A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042741A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042739A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998055614A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040486A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998027205A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998005776A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1999058642A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998046757A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998037094A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998032853A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040404A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998056909A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998021332A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998030589A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998041539A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998007855A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998001553A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998024905A3 (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2261581 Country of ref document: CA Ref country code: CA Ref document number: 2261581 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 508940 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997936173 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997936173 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997936173 Country of ref document: EP |